CeGaT Obtains CLIA Certification, Final Step Towards U.S. Market Entry

21.06.2017 | CeGaT GmbH, a leading global genetic testing provider focused on large panel and trio-exome diagnostics, has obtained its CLIA certification. ...

Safe medications thanks to new test procedures

24.05.2017 | High-Tech Gründerfonds is investing EUR 600,000 in Reutlingen-based SIGNATOPE GmbH. SIGNATOPE will use the funds to advance the development of its unique biomarker assay system, that ...

Summer Reception of BioRegio STERN Management GmbH

The summer reception of BioRegio STERN Management GmbH is an annual meeting place for entrepreneurs, researchers and founders in the BioRegion STERN as well as beyond. We would ...

CureVac Appoints Daniel Menichella as CEO of CureVac Inc., the Company’s US Subsidiary

02.05.2017 | CureVac AG, a clinical-stage biopharmaceutical company pioneering the field of mRNA-based therapies, today announced the appointment of Daniel ...